Table 2 Characteristics of the six patients receiving SST
From: Impact of systemic steroid treatment on talc pleurodesis: a report of six cases
Case number and pleurodesis outcome | Age (y) | Sex | Disease | Steroid | Route | Dose (mg/day) | NSAIDs | Serum albumin (g/dL) | Drainage volume on the day preceding pleurodesis (mL) | Pleurodesis procedures |
|---|---|---|---|---|---|---|---|---|---|---|
(1) Success | 66 | F | Rheumatoid arthritis | PSL | p.o. | 1 | Yes | 2.9 | 230 | 1 |
(2) Success | 65 | M | Kidney transplant | mPSL | p.o. | 4 | No | 2.2 | 140 | 1 |
(3) Success | 71 | M | Interstitial pneumonia | PSL | p.o. | 5 | No | 2.4 | 40 | 1 |
(4) Success | 72 | M | Radiation pneumonitis | PSL | p.o. | 5 | No | 3.0 | 1270 | 1 |
(5) Success | 66 | M | Interstitial pneumonia | PSL | p.o. | 20 | No | 3.0 | 50 | 1 |
(6) Failure | 80 | M | Nivolumab-induced pneumonia | PSL | i.v. | 40 | No | 1.7 | 300 | 2 |